총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Icosavax, Inc. (ICVX), 포함 14 건 매수 및 36 건 매도. 내부자 매수 총액은 $11.14M 내부자 매도 총액은 $16.02M.
최근 활동이 있는 주요 내부자에는 Fields Heidi, Mcdade Mark, Ra Capital Management, L.p.. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — ICVX
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2024-02-19 |
Fields Heidi |
Other: See Remarks |
주식 반환 |
17,000 |
$9.89 |
$168.13K |
- |
| 2024-02-19 |
Mcdade Mark |
Other: See Remarks |
주식 반환 |
17,000 |
$9.89 |
$168.13K |
- |
| 2024-02-19 |
Ra Capital Management, L.p. |
10 Percent Owner |
주식 반환 |
17,000 |
$9.89 |
$168.13K |
- |
| 2024-02-19 |
Veneman Ann M |
Other: See Remarks |
주식 반환 |
25,500 |
$15.00 |
$382.5K |
- |
| 2024-02-19 |
Russo Thomas Joseph |
Other: See Remarks |
공개매수 (매도) |
39,367 |
$15.00 |
$590.51K |
- |
| 2024-02-19 |
Wassil Jim |
Other: See Remarks |
주식 반환 |
17,000 |
$9.89 |
$168.13K |
- |
| 2024-02-19 |
Simpson Adam K. |
Other: See Remarks |
주식 반환 |
317,866 |
$17.55 |
$5.58M |
- |
| 2024-02-19 |
Cearley Cassia |
Other: See Remarks |
주식 반환 |
89,400 |
$17.55 |
$1.57M |
- |
| 2024-02-19 |
Kanesa-thasan Niranjan |
Other: See Remarks |
주식 반환 |
81,950 |
$17.55 |
$1.44M |
- |
| 2024-02-19 |
Shiver John W. |
Other: See Remarks |
주식 반환 |
25,500 |
$22.50 |
$573.75K |
- |
| 2024-02-19 |
Khan Amin |
Other: See Remarks |
주식 반환 |
180,000 |
$10.16 |
$1.83M |
- |
| 2024-02-01 |
Simpson Adam K. |
Chief Executive Officer |
옵션 행사 (매도) |
15,000 |
$1.04 |
$15.6K |
191,449 |
| 2024-01-22 |
Simpson Adam K. |
Chief Executive Officer |
옵션 행사 (매도) |
4,789 |
$0.84 |
$4.02K |
- |
| 2024-01-02 |
Simpson Adam K. |
Chief Executive Officer |
정보 매도 |
15,000 |
$15.67 |
$235.09K |
260,641 |
| 2023-12-21 |
Simpson Adam K. |
Chief Executive Officer |
옵션 행사 (매도) |
23,343 |
$0.84 |
$19.61K |
4,789 |
| 2023-12-20 |
Russo Thomas Joseph |
Chief Financial Officer |
정보 매도 |
4,430 |
$15.47 |
$68.51K |
38,037 |
| 2023-12-20 |
Simpson Adam K. |
Chief Executive Officer |
정보 매도 |
62,205 |
$15.46 |
$961.51K |
184,724 |
| 2023-12-20 |
Cearley Cassia |
Chief Business Officer |
정보 매도 |
7,934 |
$15.46 |
$122.64K |
130,694 |
| 2023-12-20 |
Kanesa-thasan Niranjan |
Chief Medical Officer |
정보 매도 |
11,884 |
$15.46 |
$183.69K |
223,980 |
| 2023-12-13 |
Cearley Cassia |
Chief Business Officer |
정보 매도 |
8,759 |
$16.01 |
$140.19K |
131,200 |
| 2023-08-01 |
Simpson Adam K. |
Chief Executive Officer |
옵션 행사 (매도) |
3,000 |
$0.84 |
$2.52K |
28,132 |
| 2023-07-31 |
Russo Thomas Joseph |
Chief Financial Officer |
정보 매도 |
3,066 |
$8.86 |
$27.17K |
45,620 |
| 2023-07-31 |
Simpson Adam K. |
Chief Executive Officer |
정보 매도 |
11,788 |
$8.86 |
$104.46K |
243,930 |
| 2023-07-31 |
Cearley Cassia |
Chief Business Officer |
정보 매도 |
1,888 |
$8.86 |
$16.73K |
139,959 |
| 2023-07-31 |
Kanesa-thasan Niranjan |
Chief Medical Officer |
정보 매도 |
3,323 |
$8.86 |
$29.45K |
235,864 |
| 2023-07-03 |
Holtzman Douglas |
Chief Scientific Officer |
옵션 행사 (매도) |
16,356 |
$1.04 |
$17.01K |
28,621 |
| 2023-06-12 |
Khan Amin |
EVP, Head of Research & Dev. |
처분 |
120,000 |
$9.06 |
$1.09M |
- |
| 2023-06-12 |
Khan Amin |
EVP, Head of Research & Dev. |
RSU 부여 |
180,000 |
$10.16 |
$1.83M |
180,000 |
| 2023-06-06 |
Fields Heidi |
Director |
RSU 부여 |
17,000 |
$9.89 |
$168.13K |
17,000 |
| 2023-06-06 |
Mcdade Mark |
Director |
RSU 부여 |
17,000 |
$9.89 |
$168.13K |
17,000 |
| 2023-06-06 |
Ra Capital Management, L.p. |
10 Percent Owner |
RSU 부여 |
17,000 |
$9.89 |
$168.13K |
17,000 |
| 2023-06-06 |
Veneman Ann M |
Director |
RSU 부여 |
17,000 |
$9.89 |
$168.13K |
17,000 |
| 2023-06-06 |
Wassil Jim |
Director |
RSU 부여 |
17,000 |
$9.89 |
$168.13K |
17,000 |
| 2023-06-06 |
Shiver John W. |
Director |
RSU 부여 |
17,000 |
$9.89 |
$168.13K |
17,000 |
| 2023-05-23 |
Cearley Cassia |
Chief Business Officer |
정보 매도 |
10,000 |
$10.00 |
$100K |
141,847 |
| 2023-04-03 |
Holtzman Douglas |
Chief Scientific Officer |
옵션 행사 (매도) |
20,443 |
$1.04 |
$21.26K |
44,977 |
| 2023-03-06 |
Cearley Cassia |
Chief Business Officer |
정보 매도 |
5,000 |
$7.75 |
$38.74K |
151,847 |
| 2023-02-15 |
Simpson Adam K. |
Chief Executive Officer |
옵션 행사 |
10,677 |
$1.04 |
$11.1K |
255,718 |
| 2023-02-15 |
Russo Thomas Joseph |
Chief Financial Officer |
RSU 부여 |
125,000 |
$9.06 |
$1.13M |
125,000 |
| 2023-02-15 |
Simpson Adam K. |
Chief Executive Officer |
RSU 부여 |
350,000 |
$9.06 |
$3.17M |
350,000 |
| 2023-02-15 |
Cearley Cassia |
Chief Business Officer |
RSU 부여 |
140,000 |
$9.06 |
$1.27M |
140,000 |
| 2023-02-15 |
Kanesa-thasan Niranjan |
Chief Medical Officer |
RSU 부여 |
110,000 |
$9.06 |
$996.6K |
110,000 |
| 2023-02-15 |
Holtzman Douglas |
Chief Scientific Officer |
RSU 부여 |
90,000 |
$9.06 |
$815.4K |
90,000 |
| 2023-02-15 |
Bekiroglu Elizabeth |
General Counsel & Corp. Sec. |
RSU 부여 |
100,000 |
$9.06 |
$906K |
100,000 |
| 2023-02-14 |
Holtzman Douglas |
Chief Scientific Officer |
정보 매도 |
3,349 |
$10.17 |
$34.06K |
290,054 |
| 2023-02-13 |
Russo Thomas Joseph |
Chief Financial Officer |
정보 매도 |
1,902 |
$10.69 |
$20.34K |
48,686 |
| 2023-02-13 |
Simpson Adam K. |
Chief Executive Officer |
정보 매도 |
7,506 |
$10.69 |
$80.26K |
245,041 |
| 2023-02-13 |
Cearley Cassia |
Chief Business Officer |
정보 매도 |
1,660 |
$10.69 |
$17.75K |
156,847 |
| 2023-02-13 |
Kanesa-thasan Niranjan |
Chief Medical Officer |
정보 매도 |
1,794 |
$10.69 |
$19.18K |
239,187 |
| 2023-02-13 |
Holtzman Douglas |
Chief Scientific Officer |
정보 매도 |
1,522 |
$10.69 |
$16.27K |
293,403 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료
